High‐dose‐rate brachytherapy for prostate cancer: Rationale, current applications, and clinical outcome

BACKGROUND: High‐dose‐rate brachytherapy (HDR BRT) has been enjoying rapid acceptance as a treatment modality offered to selected prostate cancer patients devoid of risk group, employed either in monotherapy setting or combined with external beam radiation therapy (EBRT) and is currently one of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Strouthos, Iosif, Karagiannis, Efstratios, Zamboglou, Nikolaos, Ferentinos, Konstantinos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8789612/
https://www.ncbi.nlm.nih.gov/pubmed/34164950
http://dx.doi.org/10.1002/cnr2.1450

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8789612/
https://www.ncbi.nlm.nih.gov/pubmed/34164950
http://dx.doi.org/10.1002/cnr2.1450

Ejemplares similares